Inhibition of bone‐derived insulin‐like growth factors by a ligand‐specific antibody suppresses the growth of human multiple myeloma in the human adult bone explanted in NOD/SCID mouse
Kazuhiro Araki(National Cancer Center Hospital East), Atsushi Ochiai(National Cancer Center Hospital East)
Cited by 25
Related Papers
Matrix Metalloproteinase-7 Facilitates Insulin-Like Growth Factor Bioavailability through Its Proteinase Activity on Insulin-Like Growth Factor Binding Protein 3
|Cancer Research|2004|154
Targeting of Bone-Derived Insulin-Like Growth Factor-II by a Human Neutralizing Antibody Suppresses the Growth of Prostate Cancer Cells in a Human Bone Environment
|Clinical Cancer Research|2009|47
Laminin 5 expression protects against anoikis at aerogenous spread and lepidic growth of human lung adenocarcinoma
|International Journal of Cancer|2005|42